申请人:Pfizer Inc.
公开号:US04486411A1
公开(公告)日:1984-12-04
6-Beta-sulfonyloxypenicillanic acid derivatives are novel beta-lactamase inhibitors, useful in combination with standard beta-lactam antibiotics against bacterial strains otherwise resistant to said beta-lactam antibiotics by dint of their production of beta-lactamases.
6-β-磺氧基青霉烷酸衍生物是新型β-内酰胺酶抑制剂,与标准β-内酰胺类抗生素结合使用,可对抗因产生β-内酰胺酶而对该类抗生素产生耐药的细菌菌株。